BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24834963)

  • 41. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations.
    Gosangari S; Dyakonov T
    Pharm Dev Technol; 2013; 18(2):475-80. PubMed ID: 22881446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro methods to assess drug precipitation.
    Dai WG
    Int J Pharm; 2010 Jun; 393(1-2):1-16. PubMed ID: 20347943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
    Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
    Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.
    Li X; Jiang C; Pan L; Zhang H; Hu L; Li T; Yang X
    Drug Dev Ind Pharm; 2015 Jan; 41(1):2-14. PubMed ID: 25026247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
    Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
    Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and application of a biorelevant dissolution method using USP apparatus 4 in early phase formulation development.
    Fang JB; Robertson VK; Rawat A; Flick T; Tang ZJ; Cauchon NS; McElvain JS
    Mol Pharm; 2010 Oct; 7(5):1466-77. PubMed ID: 20701327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UV-vis Imaging of Piroxicam Supersaturation, Precipitation, and Dissolution in a Flow-Through Setup.
    Sun Y; Chapman A; Larsen SW; Jensen H; Petersen NJ; Goodall DM; Østergaard J
    Anal Chem; 2018 Jun; 90(11):6413-6418. PubMed ID: 29746095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in dissolution instrumentation and their practical applications.
    Culen M; Dohnal J
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1277-82. PubMed ID: 24093430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro monitoring of dissolution of an immediate release tablet by focused beam reflectance measurement.
    Coutant CA; Skibic MJ; Doddridge GD; Kemp CA; Sperry DC
    Mol Pharm; 2010 Oct; 7(5):1508-15. PubMed ID: 20715796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the light scattering and the turbidity microtiter plate-based methods for the detection of the excipient-mediated drug precipitation inhibition.
    Petruševska M; Urleb U; Peternel L
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1148-56. PubMed ID: 24056092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD; Wang JX; Le Y; Zou HK; Zhao H
    Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Focused beam reflectance measurement to monitor nimodipine precipitation process.
    Xu X; Siddiqui A; Khan MA
    Int J Pharm; 2013 Nov; 456(2):353-6. PubMed ID: 24016702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical review of near-infrared spectroscopic methods validations in pharmaceutical applications.
    De Bleye C; Chavez PF; Mantanus J; Marini R; Hubert P; Rozet E; Ziemons E
    J Pharm Biomed Anal; 2012 Oct; 69():125-32. PubMed ID: 22464561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance characteristics of UV imaging instrumentation for diffusion, dissolution and release testing studies.
    Jensen SS; Jensen H; Goodall DM; Østergaard J
    J Pharm Biomed Anal; 2016 Nov; 131():113-123. PubMed ID: 27589028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A discriminatory intrinsic dissolution study using UV area imaging analysis to gain additional insights into the dissolution behaviour of active pharmaceutical ingredients.
    Hulse WL; Gray J; Forbes RT
    Int J Pharm; 2012 Sep; 434(1-2):133-9. PubMed ID: 22626886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Development and application of six-channel fiber optic sensing drug dissolution monitor].
    Yao J; Shen J; Li L; Li XX; Chen J
    Guang Pu Xue Yu Guang Pu Fen Xi; 2014 Sep; 34(9):2587-90. PubMed ID: 25532369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.